1mg, best e pharmacy in India

VOZUCA 0.3 ACTIV TABLET

Tablet
Rs.261.50for 1 bottle(s) (60 tablets each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR VOZUCA

Voglibose(0.3mg)

food interaction for VOZUCA

alcohol interaction for VOZUCA

pregnancy interaction for VOZUCA

lactation interaction for VOZUCA

medicine interaction for VOZUCA

food
alcohol
pregnancy
lactation
medicine
It is better to take Vozuca 0.3 activ tablet with food.
Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
UNSAFE
Vozuca 0.3 activ tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
PROBABLY SAFE
Unknown. Human and animal studies are not available. Please consult your doctor.
  • SERIOUS INTERACTION
    DERINIDE 0.5 MG RESPULES, RANTAC 50MG/2ML INJECTION, PEPTIRAN 75 MG/5ML SYRUP & 7 more
  • SALT INFORMATION FOR VOZUCA

    Voglibose(0.3mg)

    Uses

    Vozuca 0.3 activ tablet is used in the treatment of type 2 diabetes

    How it works

    Vozuca 0.3 activ tablet is active in the small intestine, where it inhibits enzymes which are responsible for the breakdown of complex sugar into simple sugars such as glucose. Which thereby slows the digestion of sugar in the intestines and primarily lowers the post-meal rise in blood sugar levels.

    Common side effects

    Skin rash, Flatulence, Abdominal pain, Diarrhoea

    COMMON DOSAGE FOR VOZUCA 0.3 ACTIV TABLET

    Patients taking VOZUCA 0.3 ACTIV TABLET

    • 36%
      Once A Day
    • 32%
      Thrice A Day
    • 29%
      Twice A Day
    • 1%
      Alternate Day
    • 1%
      Twice A Week
    • 1%
      Once A Week

    SUBSTITUTES FOR VOZUCA

    80 Substitutes
    80 Substitutes
    Sorted By
    RelevancePrice
    • VOLIBO 0.3 MG TABLET
      (10 tablets in strip)
      Sun Pharmaceutical Industries Ltd
      Rs. 10.80/tablet
      Tablet
      Rs. 108
      pay 148% more per tablet
    • VOLIX 0.3 MG TABLET
      (15 tablets in strip)
      Sun Pharmaceutical Industries Ltd
      Rs. 10.80/tablet
      Tablet
      Rs. 162
      pay 148% more per tablet
    • PPG 0.3 MG TABLET
      (30 tablets in strip)
      Abbott India Ltd
      Rs. 6.85/tablet
      Tablet
      Rs. 205.50
      pay 57% more per tablet
    • VOBOSE 0.3 MG TABLET
      (10 tablets in strip)
      USV Ltd
      Rs. 9.48/tablet
      Tablet
      Rs. 94.81
      pay 118% more per tablet
    • VOGO 0.3 MG TABLET
      (10 tablets in strip)
      Alembic Pharmaceuticals Ltd
      Rs. 10.32/tablet
      Tablet
      Rs. 103.25
      pay 137% more per tablet

    Top Diabetologists

    Expert advice FOR VOZUCA

    • It is very common to have flatulence, abdominal pain, diarrhoea as a side effect. To prevent this it should be taken just before each meal.
       
    • It may cause low blood sugar level (hypoglycemia) if used with sulfonylureas.
    • You should avoid using bile acid resins and antacids with Voglibose.
    • Inform your doctor if you have ever been diagnosed with chronic intestinal disorders, hernias, intestinal obstruction and intestinal ulcers.
    • Inform your doctor if you have ever been diagnosed with kidney or liver disease. Dose of your medicine may need to be adjusted.

    Frequently asked questions FOR VOZUCA

    Voglibose

    Q.

    Is voglibose/volixy approved by US FDA?
    Voglibose is not approved by US FDA

    Q.

    Is voglibose better than acarbose?
    No, voglibose and acarbose have similar overall effects but variation may exist depending on the individuals taking the drug. Always consult your doctor for an alternative drug of choice

    Q.

    Is voglibose safe?
    Voglibose is safe if used at prescribed doses for the prescribed duration as advised by your doctor.

    WHAT OUR USERS ARE SAYING ABOUT VOZUCA 0.3 ACTIV TABLET

    How effective is this medicine?

    Effective
    67%
    Can't say
    17%
    Moderately effective
    17%

    Articles


    Content on this page was last updated on 19 April, 2017, by Dr. Varun Gupta (MD Pharmacology)